Respiratory Clinic Review — Severe COPD
Dear Dr Okafor,
Thank you for your ongoing care of Mrs Glenys Marsh, whom I reviewed in clinic.
Mrs Marsh has severe COPD (post-bronchodilator FEV1 32% predicted, FEV1/FVC 0.46), GOLD group D, with frequent exacerbations. She has required non-invasive ventilation on two previous admissions for hypercapnic respiratory failure. She is a chronic CO2 retainer with a baseline SpO2 of approximately 88–90% on room air. She stopped smoking two years ago (45 pack-year history).
Her current maintenance therapy is tiotropium, fluticasone/salmeterol and a salbutamol reliever, with good inhaler technique. She is not currently on home oxygen; ambulatory assessment did not meet criteria. We have completed a written self-management plan and supplied a rescue pack of prednisone and doxycycline (she is penicillin allergic).
Importantly, given her trajectory we have begun early discussion about ceilings of treatment. She would accept NIV but has expressed she would not wish prolonged invasive ventilation. This is documented for reference during any acute admission.
Kind regards,
Dr H. Renwick